Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): RVXCF

Resverlogix Corp is a clinical stage cardiovascular company developing compounds involving a therapeutic increase in ApoA-I.
Price: $0.70 | Change: $-0.01 | % Change: -1.41%
Volume: 2,172 | Day High/Low: 0.70/0.70 | 52 Week High/Low: 3.83/0.15

View modes: 
1 star

NRI: prime take over target for GUD ?

NUVO RESEARCH INC http://www.nuvoresearch.com Latest company presentation: http://www.nuvoresearch.com/documents/presentations/2014-04-16_Nuvo_IR_Presentation_April_2014.pdf NRI has 4 FDA approved...read more
5 stars

New heart-disease guide could mean 12.8M new statin users

Interesting read: _________________________________________________________________________New statin-use guidelines divided cardiologists when they were rolled out in November, because they would put...read more
5 stars

INTERESTING BIG PHARMA ARTICLE BLOOMBERG

FYI, FOR THOSE OF INTEREST:        Boxes of Allergan Inc. Botox cosmetic are arranged for a photograph at a doctor's office in Manhattan Beach, U.S. Valeant is offering Allergan investors $48.30...read more
5 stars

RE:RE:Latest Q&A With Both Companies

toinv: That's the best we'll ever get. They don't need to consult with anyone. They have answered the best way possible. Any further information will be done for all to know and to understand going...read more
5 stars

RE:Latest Q&A With Both Companies

Thanks Sanfran for the post. These sure are bland, smug and uninspiring responses from RVX. I realize they must be very careful with regard to the issue of tipping their hand in such a way as to...read more
5 stars

RE:HDL Workshop 2014, Toronto, ON, May 3-4.

Thanks, Kelsee.  I'm a big fan of Dr. Johansson.   I am also quite interested to hear what the following person has to say as the ABCA1 Mechanism was the suspected culprit on why our drug doesn't...read more
5 stars

HDL Workshop 2014, Toronto, ON, May 3-4.

… I believe this workshop has been newly added to the events section of their website, note that RVX will be presenting on Sunday May 4th , Jan Johansson… HDL is the focus of this workshop...read more
3 stars

RE:RE:Latest Q&A With Both Companies

Answers to most of those questions would be material information.  Even if it's not, you can't expect a company to release significant new info to select people.  They'll release it publicly when they...read more
5 stars

RE:Latest Q&A With Both Companies

... correct SanFran, completely useless response from Resverlogix... very impersonal this character Patrick, imo... certainly no match for Sarah... You got quick action on the website though... who...read more
5 stars

Important Addendum to Latest Q&A

Here is an important addendum to the Q&A with Resverlogix. This information comes from two follow up questions I asked after receiving the answers from the company.  I think the second item is...read more
5 stars

RE:RE:RE:ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE

Thanks. Will take a look.  rate and reply
5 stars

RE:RE:RE:ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE

Oh, one more Biotech777. Here is their original press release that references the article I linked before. This should have all the information you felt you were lacking before. http://www.atheronova...read more
5 stars

RE:RE:ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE

Biotech777, Although Atheronova doesn't provide the citation on their webpage, here is the link for the article that includes the full data and methodology for the pre-clinical work. http://www.ncbi...read more
5 stars

RE:RE:New Treatment Tested in Animals

Yup Testy, we'll have to watch this one.   Of course, they are still in animals.  Eveyone on this board knows that that means very early daze.  And a lot can happen as they progress into human...read more
5 stars

RE:New Treatment Tested in Animals

very interesting, sf. :) this could givw rvx a run for its money in at least some markets. had to run, so fidnt finish yet.to see ehat, if anything,was said about inflammatory markers... looks like...read more
5 stars

Latest Q&A With Both Companies

Here is my latest Q&A with Resverlogix and Zenith.  Not much of interest here to me..... -------------------------------------- RESVERLOGIX QUESTION:  How will the next RVX-208 trial be financed...read more
5 stars

New Treatment Tested in Animals

Scientists alter fat metabolism in animals to prevent most common type of heart disease Read more at http://scienceblog.com/71897/scientists-alter-fat-metabolism-in-animals-to-prevent-most-common...read more
5 stars

RE:ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE

Ive been following this one for quite a while now. Its basically a bile acid which acts as a detergent for lipids. It's interesting. They are doing their clinical work in Russia which isn't a shock as...read more
5 stars

ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE

FYI FOR THOSE OF INTEREST: Developing Solutions to Treat Lipid Diseases   AHRO-001 Find out more Regression and stabilization of plaque will become the new gold standard in the treatment and...read more
5 stars

RE:A LOTTA OF BP TRANSACTIONS GOING

Addendum to lotta buying,FYI NOT F U I:      Large deals make sense for Pfizer Inc. (PFE ▲ 2.02% 30.86) and AstraZeneca Plc (AZN ▲ 6.65% 4,033.00), even if not with each other. While the talks...read more